Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Genmab Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL) June 27, 2023 From Genmab Via Business Wire Tickers GMAB Genmab Announces Epcoritamab Added to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for ‘B-Cell Lymphomas’ June 22, 2023 From Genmab Via Business Wire Tickers GMAB Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023 June 09, 2023 From Genmab Via Business Wire Tickers GMAB Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology April 17, 2023 From Genmab Via Business Wire Tickers GMAB Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) November 21, 2022 From Genmab Via Business Wire Tickers GMAB Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium June 11, 2022 From Genmab Via Business Wire Tickers GMAB Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting May 26, 2022 From Genmab Via Business Wire Tickers GMAB Genmab Announces Multiple Abstracts to Be Presented at the European Hematology Association (EHA) Annual Congress May 12, 2022 From Genmab Via Business Wire Tickers GMAB Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021) October 01, 2021 From Genmab Via Business Wire Tickers GMAB Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
